STICHTING PHARMACCESS INTERNATIONAL (FMO-58325)

Countries
  • Ghana
  • Kenya
  • Nigeria
  • Tanzania
Geographic location where the impacts of the investment may be experienced.
Financial Institutions
  • Netherlands Development Finance Company (FMO)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Approved
Stage of the project cycle. Stages vary by development bank and can include: pending, approval, implementation, and closed or completed.
Bank Risk Rating
U
Environmental and social categorization assessed by the development bank as a measure of the planned project’s environmental and social impacts. A higher risk rating may require more due diligence to limit or avoid harm to people and the environment. For example, "A" or "B" are risk categories where "A" represents the highest amount of risk. Results will include projects that specifically recorded a rating, all other projects are marked ‘U’ for "Undisclosed."
Voting Date
Jul 15, 2020
Date when project documentation and funding is reviewed by the Board for consideration and approval. Some development banks will state a "board date" or "decision date." When funding approval is obtained, the legal documents are accepted and signed, the implementation phase begins.
Borrower
STICHTING PHARMACCESS INTERNATIONAL
A public entity (government or state-owned) provided with funds or financial support to manage and/or implement a project.
Sectors
  • Industry and Trade
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
Loan
The categories of the bank investment: loan, grant, guarantee, technical assistance, advisory services, equity and fund.
Investment Amount (USD)
$ 0.30 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Currency conversion note:
Bank reported EUR 0.26 MLN
Converted using 2020-07-15 exchange rate.
Primary Source

Original disclosure @ FMO website

Updated in EWS Jun 19, 2021

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description
If provided by the financial institution, the Early Warning System Team writes a short summary describing the purported development objective of the project and project components. Review the complete project documentation for a detailed description.

PharmAccess is an international NGO headquartered in Amsterdam and offices in Sub-Sahara Africa (Kenya, Tanzania, Ghana and Nigeria) that aims at improving access to better quality care through loans for health SME's, quality standards and health insurance using mobile and digital technology.

The project aims to support healthcare providers, patients, and the local government in Ghana, with the current Covid-19 response and to ensure that the implemented processes and technologies stay in place post-Covid-19.

FMO- NLB's support will assist PhamAccess in implementing and rolling out the Covid-19 Monitor in Ghana, as the first African country to help reducing the spread of the virus and preparing the healthcare system and local authorities to better handle the COVID-19 response. The FMO development capital contribution of EUR 258,781 represents 50% of the investment required to introduce the COVID-19 Monitor as was developed by Luscii Healthtech B.V. and was in the Netherlands made available by OLVG, to Ghana where a remote care centre will be established and the solution will be made available for a USSD feature phone. After successful implementation in Ghana, it will also be made available to other countries such as Nigeria and Kenya.

 

Investment Description
Here you can find a list of individual development financial institutions that finance the project.

Contact Information
This section aims to support the local communities and local CSO to get to know which stakeholders are involved in a project with their roles and responsibilities. If available, there may be a complaint office for the respective bank which operates independently to receive and determine violations in policy and practice. Independent Accountability Mechanisms receive and respond to complaints. Most Independent Accountability Mechanisms offer two functions for addressing complaints: dispute resolution and compliance review.

Project contacts not available at the time of disclosure.

 

ACCOUNTABILITY MECHANISM OF FMO

Communities who believe they will be negatively affected by a project funded by the Dutch Development Bank (FMO) may be able to file a complaint with the Independent Complaints Mechanism, which is the joint independent accountability mechanism of the Dutch Development Bank (FMO) and the German Investment Corporation (KfW) . A complaint can be filed in writing, by email, post, or online. The complaint can be filed in English or any other language of the complainant. The Independent Complaints Mechanism is comprised of a three-member Independent Expert Panel and it can provide either problem-solving, compliance review or both, in either order. Additional information about this accountability mechanism, including a guide and template for filing a complaint, can be found at: https://www.fmo.nl/independent-complaints-mechanism

How it works

How it works